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Abstract
Streptococcus pyogenes is a Gram-positive human pathogen that is recognized by yet unknown pattern recognition
receptors (PRRs). Engagement of these receptor molecules during infection with S. pyogenes, a largely extracellular
bacterium with limited capacity for intracellular survival, causes innate immune cells to produce inflammatory mediators
such as TNF, but also type I interferon (IFN). Here we show that signaling elicited by type I IFNs is required for successful
defense of mice against lethal subcutaneous cellulitis caused by S. pyogenes. Type I IFN signaling was accompanied with
reduced neutrophil recruitment to the site of infection. Mechanistic analysis revealed that macrophages and conventional
dendritic cells (cDCs) employ different signaling pathways leading to IFN-beta production. Macrophages required IRF3,
STING, TBK1 and partially MyD88, whereas in cDCs the IFN-beta production was fully dependent on IRF5 and MyD88.
Furthermore, IFN-beta production by macrophages was dependent on the endosomal delivery of streptococcal DNA, while
in cDCs streptococcal RNA was identified as the IFN-beta inducer. Despite a role of MyD88 in both cell types, the known IFN-
inducing TLRs were individually not required for generation of the IFN-beta response. These results demonstrate that the
innate immune system employs several strategies to efficiently recognize S. pyogenes, a pathogenic bacterium that
succeeded in avoiding recognition by the standard arsenal of TLRs.
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Introduction
Streptococcus pyogenes, also known as Group A streptococcus
(GAS), is a Gram-positive human pathogen causing an exception-
ally broad range of infectious diseases [1]. The bacterium can
evoke mild illnesses such as pharyngitis or scarlet fever. Systemic
infections with S. pyogenes can develop into life-threatening diseases
such as necrotizing fasciitis and streptococcal toxic shock
syndrome that occur in ,10000 cases in the US annually resulting
in ,1500 deaths [2]. The wide spectrum of S. pyogenes-related
diseases arises from diversity in the genetic inventory of both the
host and the pathogen [3,4,5,6]. Genetic linkage analysis of mouse
strains differing in their susceptibility to S. pyogenes infections
demonstrated importance of the innate immune system [7].
Animal studies confirmed an essential role of macrophages and
dendritic cells (DCs) in protection against S. pyogenes infections
[8,9].
Innate immune cells initiate the immune response by produc-
tion of inflammatory mediators which results from the recognition
of the pathogen-associated molecular patterns (PAMPs) by pattern
recognition receptors (PRRs) [10]. Recognition of bacteria is
achieved by membrane-bound PRRs of the TLR family and by
several classes of cytosolic PRRs. In mice, 12 TLRs are known
[10,11]. They all signal through the adaptor MyD88, except for
TLR3, which employs the TRIF. TRIF is also used by TLR4,
together with MyD88. Further downstream events include the
activation of MAPKs and transcription factors of the NF-kB and
IRF families. TLR3, TLR7, TLR8 and TLR9 are localized in the
endosomal compartments whereas the remaining TLRs reside at
the cell membrane [12]. Signaling from the cell membrane-bound
TLRs leads to the production of NF-kB -driven cytokines (e.g.
TNF, IL-6) while signaling from the endosomal TLRs triggers the
induction of IRF-driven interferon beta (IFN-b) and NF-kB-driven
cytokines. The initially cell surface-localized TLR2 and TLR4
turn into IFN-b inducers after ligand-triggered internalization
[13,14]. Bacterial products that reach the cytosol can be
recognized in MyD88-independent ways by cytosolic PRRs
including nucleotide-binding and oligomerization domain
(NOD)-like receptors (NLRs), retinoic acid-inducible gene I
(RIG-I)-like receptors (RLRs) and the DNA-sensors DAI, AIM2
PLoS Pathogens | www.plospathogens.org 1 May 2011 | Volume 7 | Issue 5 | e1001345and LRRFIP1 [10,15]. NLRs and AIM2 cause inflammasome-
dependent IL-1b release. In addition, the NLR members NOD1
and NOD2 activate NF-kB -driven cytokine production [16].
RLRs, DAI and LRRFIP1 are involved in type I IFN production
in response to bacteria-derived nucleic acids.
The recognition of S. pyogenes is not understood. Although S.
pyogenes cannot divide in infected cells, phagosomal escape and a
limited cytosolic survival have been reported so that both extra-
and intracellular recognition are possible [17,18]. Studies by us
and others demonstrated that murine bone marrow-derived
macrophages (BMDMs) and conventional DCs (cDCs) responded
to S. pyogenes by a TLR2-, TLR4- and TLR9-independent
production of TNF and IL-6 [19,20]. The lack of requirement
for TLR2 is surprising since S. pyogenes contains the TLR2 ligand
lipoteichoic acid [21]. The TNF and IL-6 production was strictly
dependent on MyD88 that was also needed for survival of S.
pyogenes-infected mice [19,22]. Another route of S. pyogenes
recognition employs the activation of the Nlrp3 inflammasome
by a so far unknown ligand [23]. The inflammasome-induced IL-1
could not account for the MyD88-dependent induction of IL-6
and TNF since IL1-R1
-/- BMDMs were fully responsive to S.
pyogenes [19]. Our previous study showed that S. pyogenes induced
IFN-b in BMDMs, which was the first evidence for a Gram-
positive bacterium with mostly extracellular life cycle to do so [19].
Subsequently, the extracellular Group B Streptococcus (GBS) was
also shown to induce IFN-b in BMDMs and cDCs [24,25]. The
mechanism of IFN-b induction by S. pyogenes and the role of type I
IFN signaling in a valid infection model remained to be elucidated.
Depending on the pathogen, type I IFN signaling can have
protective or deleterious effects in infection models [26]. Here we
show that mice deficient in type I IFN signaling are susceptible to
invasive S. pyogenes infection. cDCs required MyD88 and IRF5 for
IFN-b production, while BMDMs possessed MyD88-dependent
and independent pathways that however both required IRF3. In
both cell types, IFN-b was induced in the absence of the known
IFN-b -inducing PRRs TLR3, TLR7, TLR9, NOD1 or NOD2.
Analysis of bacterial components indicated that S. pyogenes-derived
RNA was the IFN-b inducer in cDCs whereas bacterial DNA was
the inducer in BMDMs. Our data also propose that induction of
IFN-b by S. pyogenes and GBS is achieved by similar PAMPs but
different sensing mechanisms.
Results
Type I IFN signaling is required for host protection
against S. pyogenes infection in lethal cellulitis
Recent studies revealed that, depending on the pathogen, type I
IFNs may be beneficial or harmful to the host [25,27,28,29]. To
test how the S. pyogenes-induced type I IFNs contribute to host
defense, we subcutaneously infected type I IFN receptor 1-
deficient (IFNAR1
-/-) and control (WT) mice and monitored
survival over 6 days. This infection model resembles human skin
infections with S. pyogenes which give rise to cellulitis and may
develop into streptococcal toxic shock syndrome [30]. IFNAR1
-/-
mice displayed 75% lethality rate whereas only 25% of WT
controls died demonstrating essential contribution of type I IFNs
to the host defense against S. pyogenes (Fig. 1A). Inspection of
animals 2 days post challenge revealed that neutrophils were more
abundant at the site of infection in the IFNAR1
-/- mice indicating
that type I IFNs negatively regulated neutrophil recruitment
(Fig. 1B). Tissue destruction was more advanced in the wound of
IFNAR1
-/- mice (Fig. 1B) in accordance with the tissue-eroding
activity of enzymes released from neutrophils. These findings
suggest that excessive neutrophil activity at the site of infection
negatively influences the outcome of infection.
Macrophages and dendritic cells employ different
mechanisms for IFN-b induction by S. pyogenes
Macrophages (BMDMs) and cDCs are required for protection
of mice against S. pyogenes infections and for preventing
dissemination of bacteria from the primary subcutaneous inocu-
lation site [8,9]. Both cell types respond to S. pyogenes infection by a
robust TNF and IL-6 production that is MyD88-dependent and
involves a so far unidentified receptor different from the common
receptors for bacterial components i.e. TLR2, TLR4 and TLR9
[19,20]. Both cell types were also reported to induce IFN-b
although the precise mechanisms remained unknown [19,25]. We
directly compared the requirement for MyD88 in S. pyogenes-
induced IFN-b production by infecting BMDMs and cDCs
derived from MyD88
-/- and WT mice. IFN-b amounts were
measured in supernatants collected 4 and 6 hrs after infection of
cDCs, and 6 and 8 h after infection of BMDMs since the
accumulation of the cytokine in the supernatants took consistently
longer in BMDMs as compared to cDCs (Fig. S1A). No further
increase of IFN-b was observed 16 h after infection (data not
shown). The IFN-b induction was dose-dependent (Fig. S1B). In
BMDMs the amount of IFN-b was reduced by 50% in the absence
of MyD88 while the IFN-b production in cDCs was fully MyD88-
dependent (Fig. 2A, B). The lack of IFN-b induction in MyD88
-/-
was not caused by reduced phagocytosis since the number of
internalized bacteria in these cells was comparable to control cells
(Fig. 2C, D). We observed that the IFN-b-driven activation of the
transcription factor Stat1 was slightly higher in MyD88
-/- than in
WT BMDMs although the Stat1 protein levels were lower in the
knockout cells (Fig. S2A). We reasoned that the increased Stat1
activation despite of a reduced IFN-b production in MyD88
-/-
cells might be caused by the inability of MyD88
-/- cells to activate
expression of the Socs1 gene, an inhibitor of IFN signaling. Full
expression of Socs1 requires activation of the p38 MAPK [31] that
is reduced in S. pyogenes-infected MyD88
-/- cells [19]. Consistently,
Author Summary
Streptococcus pyogenes is an important human pathogen
that causes a broad range of diseases. The bacterium
colonizes the throat and the skin where it can evoke
usually mild illness such as strep throat or scarlet fever.
Systemic infections with S. pyogenes are less frequent but
can develop into life-threatening diseases such as necro-
tizing fasciitis and streptococcal toxic shock syndrome. The
immune system launches a usually successful response
that is initiated by a so far not understood recognition of
this pathogen by the cells of the innate immune system.
These cells produce upon infection a variety of cytokines
that orchestrate a full blown protective response. Among
these cytokines, type I interferons play a critical role as
demonstrated by our study. We further show that IFN-
beta, the key type I interferon, is produced only after
macrophages and dendritic cells have taken up the
pathogen and liberated the bacterial nucleic acids for
recognition in the intracellular vesicles. Importantly,
macrophages and dendritic cells recognize different
nucleic acids and employ different signaling pathways to
respond. Our data suggest that the innate immune system
employs several strategies to efficiently recognize S.
pyogenes, a pathogenic bacterium that succeeded in
avoiding recognition by the standard recognition mecha-
nisms.
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-/- BMDMs
(Fig. S2B).
In cDCs, IFN-b production induced by a variety of stimuli is
often regulated by the transcription factors IRF1 and IRF7
downstream of MyD88, whereas in BMDMs so far only IRF3-
dependent MyD88-independent induction of IFN-b has been
described [10]. Recently, IRF5 was reported to contribute to IFN-
b induction by Mycobacterium tuberculosis in BMDMs [32]. To
Figure 1. Type I IFN signaling is needed for host defense against S. pyogenes and control of neutrophil recruitment. (A) Kaplan-Meier
survival curves of C57BL/6 and IFNAR1
-/- mice (15 mice per genotype) after subcutaneous infection with 3610
8 CFU of S. pyogenes. Survival was
monitored for 6 days. Significance: ** =P value,0.01. (B) Representative HE-stained (upper panel) and Ly6G-stained (lower panel) sections of flanks
from S. pyogenes-infected control (WT) and IFNAR1
-/- mice 48 h after infection are shown. (Magnification:625). Note exaggerated tissue destruction
(upper panel) and increased neutrophil (lower panel) recruitment in samples from IFNAR1
-/- mice.
doi:10.1371/journal.ppat.1001345.g001
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we examined BMDMs and cDCs derived from IRF1
-/-, IRF3
-/-
and IRF5
-/- mice. IRF1 was dispensable, while IRF3 was
absolutely essential for IFN-b induction in BMDMs (Fig. 3A, C).
The requirement for IRF3 in BMDMs was further supported by
increased phosphorylation of IRF3 in S. pyogenes-infected BMDMs
(Fig. 3E). In contrast, IFN-b production in cDCs was partially
dependent on IRF1 but not on IRF3 (Fig. 3B, D). Interestingly,
IFN-b production was completely abolished in IRF5
-/- cDCs
which is to our knowledge the first report of such dominant effect
of IRF5 in this cell type (Fig. 3F). The data in cDCs are consistent
with a previous study describing partial dependency of S. pyogenes-
induced IFN-b on IRF1 [25]. In that study GBS-induced IFN-b in
cDCs was completely dependent on IRF1 indicating that the two
streptococcal species employ different mechanisms for IFN-b
induction in cDCs. In BMDMs, the complete dependency of S.
pyogenes-induced IFN-b on IRF3 (Fig. 3C) resembled the reported
GBS-stimulated IFN-b in the same cell type [24]. However, GBS-
induced IFN-b did not require MyD88 in BMDMs [24] whereas
our data show that upon S. pyogenes infection about 50% of IFN-b
depends on MyD88 (Fig. 2A). Together, the data illustrate that
IFN-b production in response to S. pyogenes completely requires
MyD88 and IRF5, with a limited contribution of IRF1 in cDCs;
while in BMDMs IRF3 fully controls IFN-b generation, 50% of
which is MyD88-dependent. In addition, S. pyogenes and GBS
significantly differ in the requirement for MyD88 and IRFs in
IFN-b induction, thereby further illustrating the diversity of these
streptococcal pathogens.
S. pyogenes induces IFN-b by using receptors that differ
from PRRs typically engaged by bacterial products
Our findings that cDCs fully and BMDMs partially require
MyD88 for S. pyogenes-induced IFN-b production prompted us to
test the involvement of the IFN-b-inducing MyD88-dependent
Figure 2. MyD88 is involved in IFN-b induction by S. pyogenes in BMDMs and cDCs. (A, B) IFN-b production in BMDMs is partially (A) and in
cDCs completely (B) dependent on MyD88. Cells from wild-type (WT) and MyD88
-/- mice were infected with S. pyogenes (MOI=100) or left untreated.
After indicated periods, supernatants were collected and IFN-b release was measured by ELISA. Values represent mean 6 SD; n=3. (C, D) Control
(WT) and MyD88
-/- BMDMs (C) and cDCs (D) were infected with CFSE-labeled S. pyogenes (MOI=50 and MOI=100) for 45 min. Uptake of bacteria was
determined using flow cytometry. Results are expressed as phagocytosis index, defined as the percentage of cells with internalized S. pyogenes,
multiplied by the mean fluorescent intensity. Statistical analysis (see Material and Methods) did not reveal significant differences between WT and
MyD88
-/- cells.
doi:10.1371/journal.ppat.1001345.g002
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-/- (A, B) and IRF3
-/- (C,
D) mice as well as control mice (WT) were infected with S. pyogenes (MOI=100) or left untreated. At indicated time points, supernatants were
collected and IFN-b release was measured by ELISA. SDs (n$3) are shown. (E) BMDMs were infected with S. pyogenes (MOI=100). After indicated time
points whole cell extracts were prepared. Activation of IRF3 was determined via Western Blot using an antibody against phosphorylated IRF3 (p-IRF3).
Equal loading was confirmed by reprobing the membrane with an antibody against total IRF3. (F) cDCs from IRF5
-/- and control mice were infected
with S. pyogenes and IFN-b production was measured as described in (A).
doi:10.1371/journal.ppat.1001345.g003
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cDCs was excluded in the study by Mancuso et al. [25]. Similarly,
no requirement for TLR9 was detected in BMDMs (Fig. S3) which
is in agreement with our previous data obtained using TLR2/
TLR4/TLR9-triple-deficient cells [19]. TLR7
-/- BMDMs and
cDCs infected with S. pyogenes did not differ in their ability to
generate IFN-b when compared to WT controls (Fig. 4A, B).
Similarly, deficiency in TLR3 did not result in changes of IFN-b
induction in S. pyogenes-infected BMDMs (Fig. 4C). The role of
TLR3 in cDCs has been ruled out previously [25]. Thus, neither
TLR7, shown to be needed for GBS-induced IFN-b in cDCs [25],
nor TLR3 could account for the recognition mechanism causing
IFN-b production in S. pyogenes-infected cells. To further
characterize pathways engaged in S. pyogenes recognition we
examined the function of the TANK-binding kinase 1 (TBK1), a
major activator of IRF3. Since IRF3 is essential for IFN-b
generation by S. pyogenes-infected BMDMs (Fig. 3C) we silenced
TBK1 in these cells using siRNA. Reduction of TBK1 protein
levels to approximately 20% of the non-target siRNA control
resulted in a 50% drop of IFN-b (Fig. 4D, E). Using a similar
approach, we also show a requirement for the adaptor STING
(Fig. 4F, fig.S4), which has been shown in a number of studies to
facilitate TBK1-mediated IFN-b induction [33]. The more
profound effect of silencing of STING as compared to TBK1
could reflect a more efficient silencing (perhaps due to shorter half
life of the STING protein) or activation of IRF3 by a kinase other
than TBK1 e.g. IKK-e [26]. Thus, the TBK1/STING pathway
was needed for S. pyogenes-elicited IFN-b induction in BMDMs but
the involvement of TLRs known to signal via TBK1 was not
detected. TBK1 can be activated in a TLR3-dependent MyD88-
independent way by the adaptor TRIF [10]. However, TRIF
deficiency did not result in a decreased IFN-b production in
BMDMs and cDCs (Fig. 5A, B), which was consistent with the lack
of any effect of TLR3 in these cells (Fig. 4C and [25]).
Recently, the cytosolic PRRs nucleotide-binding oligomeriza-
tion domain (NOD) 1 and 2 were unexpectedly found to be
required for IFN-b induction under certain conditions. Binding of
the NOD1 ligand, a peptide derived from bacterial peptidoglycan,
to NOD1 in epithelial cells resulted in a TBK1-dependent
production of IFN-b [34]. In the case of NOD2, binding of
virus-derived single stranded RNA (ssRNA) to NOD2 caused
activation of IRF3 and induction of IFN-b [35]. NOD2 is also
needed for IRF5-dependent IFN-b induction by M. tuberculoses-
derived peptidoglycan in macrophages [32]. We excluded the
involvement of NOD1 and NOD2 in S. pyogenes-induced IFN-b
since in BMDMs from NOD1
-/- and NOD2
-/- mice the activation
of Stat1 and production of IFN-b were comparable to WT cells
(Fig. S5A, B).
Cumulatively, the MyD88-dependent production of IFN-b in
response to S. pyogenes infection does not result from activation of
TLR7, the TLR utilizing MyD88. Furthermore, the MyD88-
independent IFN-b induction in BMDMs cannot be explained by
the activation of TLR3, NOD1 or NOD2, the PRRs employing
TBK1 and IRF3 signaling for IFN-b induction, despite the
requirement of these two signaling components for S. pyogenes–
stimulated IFN-b production.
Processing of internalized S. pyogenes is required for IFN-
b production
It is becoming increasingly clear that the recognition of nucleic
acids by innate immune cell receptors is not limited to viral
infections but appears to be a more universal way of sensing
danger signals which may originate from viruses, bacteria or even
mammalian cells [10]. The response to nucleic acids by PRRs
occurs either in the endosomal compartment or in the cytosol
ensuring successful detection in both the phagosome and, in case
of phagosomal escape of the pathogen, in the cytosol. We assumed
that the S. pyogenes-derived PAMPs were recognized primarily
during phagocytosis since S. pyogenes is not capable of further
growth after internalization, although streptolysin O (SLO)-
mediated escape from phagosome to autophagosome with a
short-lived cytosolic intermediate occurs [36,37,38]. This assump-
tion was supported by our findings that S. pyogenes-induced IFN-b
was completely dependent on MyD88 in cDCs, while only to 50%
in BMDMs (Fig. 2A, B), as the cytosolic PRRs do not signal via the
MyD88 adaptor in these cells [10]. Furthermore, heat-killed S.
pyogenes, which is assumed to lack the ability to deliver bacterial
products into the cytosol [23], retained, albeit in BMDMs to only
,50%, its capacity to induce IFN-b (Fig. S6A, B). Interestingly,
heat-killed S. pyogenes was consistently a better IFN-b inducer than
live bacteria in cDCs (Fig. S6B). To directly test the role of uptake
of S. pyogenes in IFN-b induction, we treated BMDMs with
dynasore prior to infection. Dynasore, an inhibitor of the small
GTPase dynamin that is required for internalization of coated
endosomal vesicles [39], is frequently used to assess the
contribution of endosomal signaling to IFN-b production [40].
Dynasore completely abolished S. pyogenes-mediated induction of
IFN-b (Fig. 6A). For IFN-b detection in the dynasore experiment,
we assayed IFN-b mRNA rather than protein, since dynasore
might interfere with protein secretion. To test whether dynasore
inhibited uptake of S. pyogenes, we employed differential staining of
extracellular an intracellular bacteria. S. pyogenes cells were first
labeled with carboxyfluorescein succinimidyl ester (CFSE),
followed by infection of dynasore- or untreated BMDMs. CFSE
did not reduce the viability of S. pyogenes (data not shown). Infected
cells were then fixed at 90 min and 180 min post infection, and
the extracellular cell surface-bound bacteria were stained by anti-
S. pyogenes antibodies. Ninety minutes after infection, less
internalized bacteria were found in dynasore-treated cells, but
180 min after infection, the number of internalized bacteria was
similar in dynasore-treated and untreated cells (Fig. 6B, C). It is
unlikely that the inhibition of IFN-b by dynasore reflected only a
delayed induction caused by the slower uptake since IFN-b
induction was abolished by dynasore at any time point examined
(up to 8 h, Fig. 6A). Thus, dynasore acted in steps following
phagocytosis. Since dynamin, the target of dynasore, has been
reported to affect maturation steps of phagocytic vesicles but not
their formation [41] we examined the role of phagosomal
maturation in IFN-b induction by employing bafilomycin A1, a
specific inhibitor of the phagosomal H
+ ATPase. Bafilomycin A1
blocked IFN-b production by S. pyogenes-infected BMDMs
(Fig. 6D), suggesting that hydrolytic degradation of the pathogen
was a critical event in IFN-b induction. However, the maturation
of phagosomes was not needed for killing of bacteria, as
demonstrated by comparable numbers of surviving bacteria in
dynasore- or bafilomycin A1-treated and control cells (Fig. 6E).
Similar effects of bafilomycin A1 were observed also in cDCs (data
not shown), suggesting that the hydrolytic processing of internal-
ized bacteria is fundamental for IFN-b induction in both BMDMs
and cDCs.
Endosomal delivery of S. pyogenes-derived RNA and DNA
activate IFN-b production in cDCs and BMDMs,
respectively
Microbial nucleic acids liberated during processing within the
host cells serve often as danger signals. Accordingly, RNA from
GBS was reported to induce IFN-b in a TLR7-dependent way in
cDCs [25]. To test the role of S. pyogenes-derived nucleic acids in
Type I Interferon Induction by S. pyogenes
PLoS Pathogens | www.plospathogens.org 6 May 2011 | Volume 7 | Issue 5 | e1001345Figure 4. Analysis of TLR3, TLR7, TBK1 and STING in induction of IFN-b by S. pyogenes. BMDMs (A) and cDCs (B) from TLR7
-/- and control
(WT) mice were infected with S. pyogenes (MOI=100) for the indicated periods or left untreated. Supernatants were collected and IFN-b release was
measured by ELISA. SDs (n$3) are shown. (C) BMDMs from TLR3
-/- and control (WT) mice were infected with S. pyogenes and IFN-b production was
measured as described in (A). (D) Silencing of TBK1 was monitored by Western blot analysis of extracts prepared from cells used in (E). TBK1
expression was determined using an antibody against TBK1. Equal loading was determined by re-probing the membrane with an antibody to p38
MAPK. (E, F) BMDMs transfected with siRNA specific for TBK1 (E), STING (F) or non-target control siRNA were infected with S. pyogenes and IFN-b
production was measured as described in (A). SDs (n=3) are shown.
doi:10.1371/journal.ppat.1001345.g004
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with DNase I, RNase A, proteinase K or left untreated (control
extract) were delivered into the cells using DOTAP. DOTAP is
known to be taken up together with the bound cargo by the
endocytic pathway [42]. S. pyogenes-derived complete extracts and
the RNA-containing fraction where able to induce IFN-b in
cDCs which was however not dependent on TLR7 (Fig. 7A). This
was in agreement with the TLR7-independent IFN-b induction
by live S. pyogenes (Fig. 4B) and supported our notion of distinct
mode of IFN-b induction by S. pyogenes and GBS. To further
substantiate the critical role of S. pyogenes-derived RNA in IFN-b
induction in cDCs, we examined responses of MyD88
-/- cells to
extracts from S. pyogenes. Responses of cDCs to the bacterial
RNA-containing extracts were fully abolished in MyD88
-/- cells
(Fig. 7B), which virtually mirrored the infection of cDCs with live
S. pyogenes (Fig. 2B). Importantly, DOTAP-mediated delivery did
not result in the activation of the cytosolic nucleic acid sensors
NLRs, RLRs (RIG-I, MDA5 and LGP2), DAI or the recently
reported LRRFIP1 since these PRRs signal independently of
MyD88 [15,34,35,43,44]. To further support this notion we
tested the adaptor MAVS (also called IPS-1, CARDIF, or VISA)
that acts downstream of the RIG-I and MDA5 RNA sensors.
cDCs derived from MAVS
-/- mice responded to S. pyogenes-
derived RNA-containing extracts or to infection with live S.
pyogenes by normal IFN-b induction (Fig. 7C and Fig. S7).
Together, these results suggested that the S. pyogenes extracts
administered using DOTAP represented a simplified yet still
correct delivery of S. pyogenes-derived PAMPs to their authentic
PRRs. We employed endosomal delivery to examine IFN-b
induction by S. pyogenes-derived nucleic acids also in BMDMs.
The experiment revealed that S. pyogenes-derived DNA but not
RNA was required for IFN-b induction (Fig. 7D). The DNA-
mediated IFN-b induction was even consistently increased after
removal of RNA, which might be due a successful competition of
the more abundant RNA for the DNA receptor. A concentration-
dependent interference of deoxyribonucleic with ribonucleic acids
with respect to TLR binding has been described [45]. Because of
the involvement of DNA, we re-examined the function of TLR9.
Treatment of TLR9
-/- BMDMs with S. pyogenes extracts revealed
that TLR9 did not accomplish the recognition of S. pyogenes-
derived DNA if RNA was removed (Fig. 7D). In contrast, the
control extracts (i.e. containing both RNA and DNA) induced
IFN-b in a TLR9-dependent way, suggesting that in the presence
of RNA, the recognition of bacterial DNA is achieved by TLR9,
whereas in the absence of RNA the recognition is shifted to a
different PRR. Nevertheless, the overall contribution of TLR9 to
S. pyogenes-induced IFN-b is negligible since TLR9
-/- BMDMs
infected with live S. pyogenes produced comparable amounts of
IFN-b (Fig. S3). Similar to induction by live S. pyogenes (Fig. 6A),
the induction of IFN-b by S. pyogenes–derived DNA required a
dynasore-sensitive step (Fig. S8).
Together, our data reveal that bacterial DNA and RNA are key
players in induction of IFN-b by S. pyogenes-infected BMDMs and
cDCs, respectively. Bacterial nucleic acids were in a number of
studies reported to induce IFN-b although the mechanism is often
not understood [46]. To directly compare the IFN-b-inducing
properties of nucleic acids, we stimulated cDCs and BMDMs with
purified RNA (for cDCs) or DNA (for BMDMs) from Gram-
positive extracellular (GBS, Staphylococcus aureus), mostly extracel-
lular (S. pyogenes) and intracellular (Listeria monocytogenes) bacteria
and, for comparison, the RAW murine macrophages. cDCs
displayed differential sensitivity to the tested RNA molecules.
Whereas bacterial RNA robustly induced IFN-b, mammalian
RNA failed to do so (Fig. 7E). In contrast, DNA of bacterial and
mammalian origin were all capable of inducing IFN-b to similar
levels which however remained 3-5 times lower than the levels
activated by the known IFN-b inducer poly(dA:dT) (Fig. 7F).
Consistently, linearized gel- and absorption column-purified
pGEX plasmid DNA was also able to induce IFN-b (Fig. S9).
None of the DNAs tested was able to induce TNF production
suggesting that these DNA preparations did not contain significant
amounts of other PAMPs (e.g. LTA) that could have provided a
second stimulus potentially needed for IFN-b production (Fig.
S10). Thus, in this simplified model of nucleic acid delivery, DNA
was in general capable of IFN-b induction while the IFN-b-
inducing properties of RNA were restricted to the bacterial
molecules. It should be noted that, similar to infection with live S.
pyogenes, IFN-b induction by the relevant nucleic acids was more
robust in cDCs than in BMDMs, suggesting that cDCs might be
the more important IFN-b producers in vivo.
Figure 5. TRIF is not required for S. pyogenes-mediated IFN-b production. BMDMs (A) and cDCs (B) from control (WT) and TRIF
-/- mice were
infected with S. pyogenes (MOI=100). After indicated time points, supernatants were collected and IFN-b release was measured using ELISA. SDs
(n$3) are shown.
doi:10.1371/journal.ppat.1001345.g005
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Recognition of Gram-positive extracellular bacteria was long
thought to be primarily driven by interactions between TLR2 and
the bacteria-derived LTA or lipoproteins [47]. It was therefore
surprising that the recognition of S. pyogenes and GBS occurred
independently of TLR2 although both species produce TLR2
ligands [19,20,21,48,49]. Subsequent studies by us and others
demonstrated that both S. pyogenes and GBS were also able to
induce IFN-b in innate immune cells. Despite these similarities, S.
pyogenes and GBS share only about 200 out of ,2000 genes, and
cause different diseases [50]. Although both pathogens have
extracellular life cycles, without the ability of replication within
host cells, S. pyogenes can invade and survive for several days in
nonphagocytic cells [17,18].
We provide evidence that type I IFN signaling is required for
survival of mice challenged with S. pyogenes in a model of invasive
subcutaneous infection. During the innate immune system-
controlled phase of infection, type I IFNs regulate in multiple
ways the host response. Type I IFNs can inhibit chemokine (e.g.
CXCL1 and CXCL2) expression and thereby reduce recruitment
of neutrophils to the site of infection in case of secondary
pneumococcal pneumonia [51]. While the decreased neutrophil
presence diminishes the local antibacterial activity, it also limits
tissue damage and dissemination of bacteria. Consequently, both
beneficial as well as detrimental effects of neutrophil infiltration
were reported [51,52]. Whether and how the higher neutrophil
numbers and the more pronounced tissue destruction, which we
have observed at the site of infection in the IFNAR1
-/- animals,
contribute to the increased susceptibility to S. pyogenes will be
investigated in future studies.
In bacterial infections, the type I IFN-producing cells are
predominantly macrophages and cDCs, rather than plasmacytoid
DCs [25,53]. We therefore focused on macrophages and cDCs,
the cell types required for successful defense of mice against S.
pyogenes [8,9]. We examined the production of IFN-b as the first
type I IFN to be synthesized during infections [54]. BMDMs and
cDCs displayed common as well as unique features with regard to
the induction of IFN-b. In both cell types MyD88 fulfilled an
important role, although in BMDMs about 50% of the generated
IFN-b was independent of MyD88. In cDCs, the complete
dependence on MyD88 was accompanied with a requirement for
IRF5 and partially IRF1, which was consistent with the current
view positioning these IRFs downstream of MyD88 [10]. This
canonical MyD88/IRF axis was described to be triggered by
TLR7 or TLR9 which we however ruled out as the S. pyogenes-
sensing and IRF-activating TLRs in cDCs. The involvement of
TLR8, the only IFN-b-inducing MyD88-dependent TLR not
experimentally tested by us, is unlikely, since TLR8 possesses an
inhibitory function in cytokine production [55]. The involvement
of TLR11 and TLR12, the least understood MyD88-dependet
TLRs, cannot be excluded although these PRRs were so far not
associated with type I IFN induction. Thus, the identity of the
PRR responsible for triggering the MyD88/IRF pathway in the
response of cDCs to S. pyogenes remains to be determined.
In BMDMs, about half of the induced IFN-b was MyD88-
independent yet it required IRF3, the IRF3 kinase TBK1 as well
as the adaptor STING. TBK1/IRF3 can be activated by TLR3
and TLR4 via the adaptor TRIF rather than MyD88. Our data
demonstrate that TRIF-deficient cells respond normally to S.
pyogenes suggesting that TLR3 and TLR4 were not the upstream
activators of the TBK1/IRF3 module. We confirmed this
conclusion by the analysis of TLR3
-/- BMDMs. TLR4 was
disqualified already in our previous study [19]. For the MyD88-
dependent IFN-b production we could now also exclude the
involvement of TLR7 and TLR9. Thus, both the MyD88-
dependent and -independent IFN-b production is induced by S.
pyogenes independently of TLRs. Since we tested the TLRs as well
as the adaptors MyD88 and TRIF in single knockouts we cannot
exclude a redundant use of these PRRs and adaptor molecules.
TBK1/IRF3 can be activated by various cytosolic sensors [10].
The signaling by these cytosolic PRRs does not require MyD88,
hence only the MyD88-independent part of IFN-b induction could
potentially be explained by these molecules. Our experiments
using BMDMs deficient in NOD1 and NOD2, two cytosolic PRRs
recently shown to activate the TBK1/IRF pathway [32,34,35] and
known to recognize peptidoglycan from both Gram-positive and
–negative bacteria [56], ruled out a role of these PRRs in S.
pyogenes-induced IFN-b induction.
The nature of the IFN-b-inducing bacterial product was tested
by delivering complete S. pyogenes extracts or extracts depleted of
DNA, RNA or protein to endosomes. The endosomal route was
chosen since IFN-b production in S. pyogenes-infected cells was
blocked by dynasore and bafilomycin A. Our observation that
dynasore did not inhibit the uptake is consistent with reported
function of the dynasore target dynamin in early pre-acidification
steps of phagosome maturation, rather than in phagosome
formation [41]. Thus, both dynasore and bafilomycin A are likely
to have interfered with hydrolytic degradation of the internalized
bacteria. This processing was not required for killing of bacteria
since the survival of internalized S. pyogenes was not enhanced in
cells treated with dynasore or bafilomycin A. This finding suggests
that the initially formed immature phagosomes are already fully
capable of killing S. pyogenes, and no further signaling-dependent
maturation is required. The effect of dynasore and bafilomycin A
could also be explained by the requirement of the PRRs for an
environment restricted to mature phagosomes. Our data pointing
at S. pyogenes-derived RNA as the principle IFN-b inducer in cDCs
are consistent with a model wherein the RNA is liberated from the
bacterial cells upon processing in phagosomes. The bacterial RNA
is then sensed by an endosomal receptor that triggers the IFN-b-
inducing MyD88/IRF pathway. This model is further supported
Figure 6. IFN-b production in response to S. pyogenes depends on phagosome maturation. (A) BMDMs pretreated (for 45 min) with
dynasore or left untreated were infected with S. pyogenes (MOI=100) for the indicated periods or left uninfected. At the indicated time points total
RNA was isolated, reverse-transcribed and analyzed by qPCR for IFN-b. HPRT was used for normalization. Values represent mean 6 SD; n=3. (B)
BMDMs pretreated (for 45 min) with dynasore or left untreated were infected with CFSE-labeled (green) S. pyogenes (MOI=100) and fixed at indicated
time points. Extracellular S. pyogenes were stained with anti-S. pyogenes antibody (red). The percentages of internalized S. pyogenes were calculated
based on the number of red and green fluorescing bacteria in a field. At least five fields were counted and SDs were calculated. (C) Fluorescence
microscopy imaging of cells treated as described in (B). Total S. pyogenes labeled with CFSE (green) and extracellular S. pyogenes stained post-fixation
with anti-S. pyogenes antibody (red), as well as merge are shown. Green cells in the merge image represent internalized bacteria. Representative
panels are shown. (D) BMDMs pretreated (for 45 min) with bafilomycin A1 or left untreated were infected with S. pyogenes (MOI=100). At indicated
time points, supernatants were collected and IFN-b release was measured as described in (A). Values represent mean 6 SD; n=3. (E) BMDMs treated
with dynasore, bafilomycin A or left untreated were infected with S. pyogenes (MOI=100). At indicated time points, serial dilutions of cellular lysates
were plated to count colony-forming units (CFUs) that are displayed as log CFU.
doi:10.1371/journal.ppat.1001345.g006
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PLoS Pathogens | www.plospathogens.org 10 May 2011 | Volume 7 | Issue 5 | e1001345Figure 7. S. pyogenes-derived RNA and DNA delivered to endosomes induce IFN-b in cDCs and BMDMs, respectively. S. pyogenes cells
were sonicated and the extracts were treated with either DNase I, RNase A, Proteinase K, or left untreated (control extract). The extracts and a reagent
control were delivered into cDCs derived from TLR7
-/- (A), MyD88
-/- (B) and MAVS
-/- (C) or control (WT) mice using DOTAP. After stimulation for 6 h,
supernatants were collected and IFN-b release was measured using ELISA. Values represent mean 6 SD; n=3. (D) BMDMs from TLR9
-/- and control
(WT) mice were transfected with streptococcal extracts as described in (A). After 8 h supernatants were collected for IFN-b measurements by ELISA.
(E) Purified RNA (5 mg) from S. pyogenes (SP), Group B streptococcus (GBS), Staphylococcus aureus (SA), Listeria monocytogenes (LM) and RAW 264.7
cells (RAW) were delivered into cDCs using DOTAP. After stimulation for 6 h supernatants were collected and IFN-b release was measured. Values
represent mean 6 SD; n=3. (F) DNA (5 mg) from same organisms as in (E) as well as poly(dA:dT) were delivered into BMDMs and 8 h later IFN-b
release was determined as in (E).
doi:10.1371/journal.ppat.1001345.g007
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dependent on MyD88 thereby fully recapitulating signaling upon
infection with live bacteria. Thus, we ruled out DOTAP-mediated
misguiding of bacterial RNA to the cytosol where it could generate
an artificial IFN-b response caused by the activation of cytosolic,
i.e. MyD88-independent, PRRs. This was further confirmed by
normal IFN-b response of cells deficient in MAVS, the adaptor
downstream of the cytosolic RNA sensors RIG-I and MDA5. One
reason for the involvement of MyD88 could be the need for a
second, i.e. MyD88-dependent, signal in the IFN-b induction. The
S. pyogenes extracts contained bacterial products (e.g. LTA) that
could trigger MyD88. However, we observed similar IFN-b
induction also by purified nucleic acids suggesting that a linear
pathway was activated. Bacterial RNA as an inducer of IFN-b in
cDCs has been reported for GBS [25]. However, GBS required
TLR7 for sensing whereas S. pyogenes did not although both species
employed MyD88. In BMDMs the IFN-b-inducing S. pyogenes
extracts required the presence of bacterial DNA rather than RNA.
TLR9-deficiency reduced detection of DNA in the complete
extracts but not in extracts devoid of RNA. Thus, RNA appeared
to channel bacterial DNA to TLR9. Alternatively, RNA might
prevent DNA from escaping to the cytosolic PRR. Nevertheless,
TLR9 does not play a decisive role in S. pyogenes sensing since IFN-
b induction by live bacteria was independent of this PRR. This
PRR signals via TBK1, STING and IRF3 in a partially MyD88-
dependent way. Comparison with GBS-induced IFN-b by
BMDMs reveals some parallels but also important differences
[24]. Both pathogens signal via bacterial DNA and employ the
TBK1/IRF3 pathway. For GBS it was proposed that the bacterial
DNA escaped in a pore-forming-toxin-dependent way from the
phagosomes into the cytosol of infected cells where it was sensed
by an unknown IFN-b-inducing cytosolic PRR. However, the
production of IFN-b was independent of MyD88 and required live
bacteria, which is in marked difference to S. pyogenes. The
proportion of IFN-b that was induced by S. pyogenes independently
of MyD88 might be triggered by bacterial products liberated from
the phagosome or during the short cytosolic presence of S. pyogenes.
These products would then be accessible to cytosolic PRRs like
RNA polymerase III, NLRs, RLRs, or DAI that all signal
independently of MyD88 [34,35,43,44,57,58]. We ruled out an
exclusive sensing function of the recently identified cytosolic DNA
sensor LRRFIP1 [15] since LRRFIP1 does not cause phosphor-
ylation of IRF3, which is in contrast to our observation of S.
pyogenes-induced IRF3 phosphorylation. To our knowledge the so
far only reported cytosolic MyD88-dependent DNA sensors are
the DHX9 and DHX36 helicases in plasmacytoid DCs [59].
Further studies are needed to clarify the role of these or related
helicases in responses of BMDMs to S. pyogenes. Expectedly, the
ability of S. pyogenes-derived DNA to induce IFN-b in BMDMs was
not unique since other bacterial, mammalian or plasmid DNA
molecules were also potent inducers. However, the IFN-b
induction by RNA in cDCs was accomplished only by RNA from
the tested Gram-positive bacteria but not mammalian cells. Thus,
bacterial RNA must possess specific determinants recognized by
host cells. In support of this, single-stranded RNA from Gram-
positive bacteria but not Gram-negative bacteria was recently
found to induce TNF in macrophages [60].
This study delineates the importance of type I IFN induction by
innate immune cells for successful defense against S. pyogenes.I na
similar infection model, MyD88 was recently found to be required
for full blown immune response and survival [22]. Since our data
reveal that MyD88 plays a critical role in the induction of IFN-b,i t
is conceivable that the decreased IFN-b production contributed to
the high susceptibility of MyD88-deficient mice to the infection.
Furthermore, comparison of BMDMs and cDCs revealed different
mechanism of IFN-b induction. Both cell types employ unknown
nucleic acid-sensing PRRs for IFN-b induction. It is striking that
the PRRs required for the NF-kB -driven induction of TNF and
IL-6 in S. pyogenes-infected BMDMs and cDCs have so far also not
been identified [19,20]. It appears that a successful recognition of
S. pyogenes by the host and the full blown immune response strongly
depend on functional phagocytosis and, consequently, on
professional phagocytic cells. These cells and their ability to
launch type I IFN production can prove important targets for
therapeutical intervention.
Materials and Methods
Bacterial strains and culture
The Streptococcus pyogenes serotype M1 strain ISS 3348 (provided
by Roberta Creti, Instituto Superiore di Sanita, Italy) was used for
in vitro as well for in vivo experiments [61]. S. pyogenes was grown at
37uC with 5% CO2 without agitation in Todd-Hewitt-Broth (BD
Biosciences) supplemented with 0.2% yeast extract and on
trypcase soy agar containing 5% sheep blood (Biomerieux). The
cell growth was turbidimetrically monitored at 620 nm with a
microplate reader until mid-log phase was reached. For prepara-
tion of heat-killed S. pyogenes, bacteria were grown to mid-log
phase, washed twice with sterile PBS and incubated for 20 min at
70uC in a water bath. Streptococcus agalactiae (Group B Streptococ-
cus, GBS) NEM316 and Listeria monocytogenes LO28 were grown at
37uC in brain heart infusion broth (Difco). Staphylococcus aureus
25923 was grown at 37uC in Mueller-Hinton broth (Merck).
Mice
IFNAR1
-/-, MyD88
-/-, IRF1
-/-, IRF3
-/-, TLR3
-/-, TLR7
-/-,
TRIF
-/-, TLR9
-/-, IRF5
-/- and MAVS
-/- mice on C57BL/6
background were housed under specific pathogen-free conditions.
C57BL/6 WT mice were purchased from Charles River
Laboratories.
Experimental model of S. pyogenes infection
Age- and sex-matched, pathogen free, 8–10 week old WT and
IFNAR1
-/- mice (all C57BL/6) were used in all experiments. S.
pyogenes strain ISS 3348 was grown for 4 hours to mid-logarithmic
phase at 37uC using Todd-Hewitt-Broth (BD Biosciences),
harvested by centrifugation at 6.500 rpm for 8 min, and washed
twice in sterile isotonic saline. Bacteria were then resuspended at a
concentration of 1610
8 CFU per 50 ml as determined by plating
serial 10-fold dilutions on blood agar plates. Mice were lightly
anesthetized by inhalation of isoflurane (Baxter) and the fur at the
flank was partially removed by shaving. The inoculum was
injected subcutaneously in one flank of each mouse. Survival of
mice was monitored every 4–8 hours. Survival curves were
analyzed by the Logrank Test in GraphPad Prism 4 (GraphPad
software, San Diego, USA). All data are presented as mean SD.
Comparison between two groups was performed using t-test. P
values #0.05 were considered as significant.
Cell culture
Primary bone marrow derived macrophages (BMDMs) and
conventional dendritic cells (cDCs) were obtained from the femur
and tibia bone marrow of 6–10-week old mice (all C57BL/6).
Macrophages were cultivated in Dulbeccos modified Eagle’s
medium (DMEM) supplemented with 10% fetal calf serum
(GIBCO) in the presence of L929-cell derived CSF-1, as described
[19]. Dendritic cells were cultivated for 7 days in DMEM
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cell-derived GM-CSF as described [62].
S. pyogenes infection in vitro
For infection assays, BMDMs and cDCs were seeded on 6-cm
dishes (2610
6 cells/dish) in DMEM containing 10% FCS and L-
cell-derived CSF-1 or X-6310 cell derived GM-CSF, respectively,
without antibiotics. The cells were then infected as described
previously [19]. In experiments with heat-killed S. pyogenes equal
amounts of heat-killed and live bacteria (MOI=100) were used for
infection. Infections under conditions of blocked endocytosis were
performed by pretreatment of cells with dynasore (Sigma-Aldrich,
8 mM) for 45 min prior to infection with S. pyogenes. For inhibition
of phagosomal acidification, bafilomycin A1 (Santa Cruz, 1 mM)
was added to cells 45 min prior to infection with S. pyogenes.
Determination of colony forming units (CFUs)
2610
5 BMDMs and cDCs were seeded per well in a 24-well
plate. Cells were left untreated or were pretreated with dynasore
(8 mM) or bafilomycin A1 (1 mM) for 45 min before infection with
S. pyogenes (MOI=100). Infection was carried out as described
above. 1 and 3 hours after infection, extracellular bacteria were
removed by washing with sterile PBS and macrophages were lysed
with 500 ml distilled water. Serial dilutions of cellular lysates were
plated on TSA blood agar plates (Biomerieux) and the number of
CFUs was determined by colony counting after growth for
24 hours at 37uC.
Phagocytosis assays
The uptake of S. pyogenes was analyzed as described previously
[63,64]. BMDMs and cDCs of control (WT) or MyD88
-/- mice
were seeded in 12-well-plates (5610
5 cells/ml). Cells were infected
with CFSE-labeled S. pyogenes (MOI=50 and MOI=100) for
45 min at 37uC as described above. Phagocytosis was terminated
by incubation at 4uC and addition of 1 ml ice-cold PBS. cDCs
were then transferred to FACS-tubes and washed with PBS prior
to treatment with proteinase K (1 ml/tube, 50 mg/ml, Promega)
for 10 min at room temperature to remove surface-adherent S.
pyogenes. Cells were washed twice with PBS and suspended in
trypan blue-containing PBS (200 mg/ml) to quench remaining
extracellular bacteria. Uptake was analyzed using a flow cytometer
(Beckton Dickinson FACScalibur) and results are expressed as
phagocytosis index, defined as the percentage of cells with
internalized S. pyogenes multiplied by the mean fluorescent
intensity. The same procedure was followed when using adherent
BMDMs with the exception of incubating BMDMs with CFSE-
labeled bacteria at 37uC and 4uC for 45 min. Non-phagocytosed
bacteria were removed by washing adherent monolayer cells with
PBS and surface-adherent S. pyogenes were digested using
proteinase K. No trypan blue was used in case of BMDMs since
quenching of extracellular bacteria was replaced by subtracting
mean fluorescence multiplied by the percentage of positive cells at
4uC from mean fluorescence multiplied by percentage positive
cells at 37uC. Statistical analysis was performed using the Graph
Pad Prism 5 Program (Graph Pad Software, San Diego, USA).
Differences between WT and MyD88
-/- mice were analyzed by
one-way ANOVA followed by Dunn’s post test. Criteria for
significance were p,0.05.
Generation and transfection of S. pyogenes extracts
S. pyogenes was grown to OD620=0.3 and 5 ml aliquots of the
bacterial suspensions were spun at 6.500 rpm for 8 min. The
bacteria were resuspended in 400 ml sterile PBS followed by
disruption using a Bandelin Sonopuls GM70 sonicator for
362 min. Remaining debris was removed by centrifugation at
13.200 rpm for 15 min at 4uC. The supernatants were pooled,
adjusted to contain 2 mM MgCl2, 50 mM KCl and 20mM Tris-
HCl (pH 8) and divided into four aliquots. The same was done
with sterile PBS for the reagent control. Remaining extract was
frozen at 220uC for later usage. Aliquots were digested with
DNase I (Roche, 100 U/ml), RNase A (Roche, 333 mg/ml) or
proteinase K (Sigma-Aldrich, 1 mg/ml) or left-untreated (control
extract). Extracts treated with either DNase I or RNase A were
incubated at 37uC for 45 min, extracts digested with proteinase K
were incubated for 1 hour at 37uC. After incubation, EGTA for
proteinase K (final 2 mM) treatment or EDTA (pH 8, final
2.5 mM) for DNase I and RNase A treatment were added to
extracts. In case of the reagent control and control extract, both
EGTA and EDTA were used. The extracts were then incubated at
70uC for 10 min and centrifuged for 5 min at 13.200 rpm at 4uC.
Supernatants were collected and subsequently frozen at 220uC
until use. 10 ml of these extracts (containing 5 mg of nucleic acids)
were then allowed to form complexes with 30 ml DOTAP (Roche).
Transfections were carried out in 6-cm dishes containing 2610
6
BMDMs or cDCs in 1 ml/dish, according to the manufacturers
instructions.
DNA and RNA preparation from bacteria and transfection
of cells
Isolation of bacterial DNA and RNA was performed according
to standard techniques, with some modifications [65]. Briefly, for
RNA isolation bacteria were grown to mid-log phase and lysed
using 2% SDS and 1 mg/ml proteinase K (Sigma-Aldrich). For
isolation of RNA, Trizol LS reagent (Invitrogen) was used.
Afterwards, RNA was treated with DNase using TURBO DNA-
free (Ambion). For DNA preparation, over-night cultures of
bacteria were harvested, resuspended in TE buffer (10 mM Tris-
HCl pH 8, 1 mM EDTA) and treated with lysozyme (Sigma,
2,5 mg/ml) for 30 min at 37uC. Then, heat-inactivated RNase A
(Roche, 10 mg/ml), 20% SDS and 0,5 M EDTA were added.
After incubation for 40 min at 37uC, 20 mg/ml Proteinase K was
added and further incubated for 30 min at 37uC. DNA was
isolated using Phenol:Chloroform:Isoamylalcohol (Sigma-Aldrich).
After isolation, bacterial DNA was treated with RNase A (10 mg/
ml) for 30 min at 37uC. BMDMs or cDCs (2610
6 cells per 6-cm
dish) were seeded 24 h prior to transfection with 5 mg DNA or
RNA using DOTAP as described for transfection of bacterial
extracts. The transfection mixture was added to dishes containing
1 ml (for BMDMs) or 3 ml (for cDCs) medium.
Isolation of DNA and RNA from mammalian cells
For isolation of DNA, RAW 267.4 cells were lysed in direct
PCR tail lysis buffer (Peqlab) at 55uC over night. DNA was then
isolated using Phenol:Chloroform:Isoamylalcohol (Sigma-Aldrich).
After isolation, DNA was treated with heat-inactivated RNase A
(10 mg/ml) for 30 min at 37uC. RNA was isolated using Trizol LS
reagent (Invitrogen) and treated with DNase using TURBO DNA-
free (Ambion).
Histology
The pyogenic lesions or control flanks (PBS-injected) of infected
IFNAR1
-/- and WT mice were removed 48 hours after S. pyogenes
injection. The tissue samples were fixed in 4% formalin and
subsequently embedded in paraffin. 4 mm sections were stained
with hematoxylin-eosin. Immunohistochemical staining of granu-
locytes was performed as described previously [66]. Briefly, the
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of pepsin 0.25% (Sigma-Aldrich) in 0.01; HCL. After being rinsed
the slides were exposed to FITC-labeled rat anti-mouse Ly6G
antibody (BD Biosciences) or corresponding isotype control IgG
(Emfret Analytics, Germany) followed by a further incubation with
rabbit anti-FITC Ab (Zymed, Invitrogen) in normal mouse serum.
Finally the sections were incubated with polyclonal anti-rabbit-
HRP Ab (Immunologic, The Netherlands) and visualized using
3,3-diaminobenzidine-tetrahydrochloride (Vector Laboratories,
Burlingame, CA). Counterstaining was done with hemalaun
solution.
Fluorescence microscopy
BMDMs were seeded on glass cover slips (5610
5 cells/3,5 cm
dish) in DMEM containing 10% FCS and L-cell-derived CSF-1,
without antibiotics. Cells were infected with CFSE-labeled S.
pyogenes (MOI=100) as described above. Infections were per-
formed after pretreatment or mock-treatment of cells with
dynasore (Sigma-Aldrich, 8 mM) for 45 min prior to infection.
At the indicated time points, cells were fixed with 1%
formaldehyde, blocked with 1% BSA in PBS and incubated with
primary anti-S. pyogenes rabbit antibody (kind gift from I. Julkunen),
followed by Alexa Fluor 594 goat anti-rabbit IgG (Invitrogen).
Cover slips were mounted on microscope slides with Fluorescent
mounting medium (Dako). To quantify the ratio of internalized S.
pyogenes, green and red fluorescent bacteria were counted under
GFP and rhodamine filters, respectively. The percentage of
internalized bacteria was calculated by subtracting the number
of external bacteria (red) from the total number of CFSE-labeled
bacteria (green), then dividing by the number of CFSE-labeled
bacteria.
Cytokine measurement
IFN-b in supernatants of infected macrophages and dendritic
cells was measured by ELISA using the VeriKine Mouse
Interferon Beta Kit (PBL Biomedical Laboratories), according to
the manufacturers instructions. Samples were applied undiluted.
TNF in supernatants of infected macrophages were assayed using
a DuoSET ELISA kit (R&D Systems). Samples were diluted 1:2 in
reagent diluent.
Antibodies
Antibodies to Tyr701-phosphorylated Stat1 (pY701-S1), phos-
pho-IRF-3 (Ser396) and TBK1 were purchased from Cell
Signalling. The antibody against p38 MAPK was from Santa
Cruz Biotechnology, the antibody against IRF3 was from Zymed
(Invitrogen). The antibody to Stat1-C-terminus was previously
described [67].
Western blot analysis
After treatment, whole cell extracts were prepared and assayed
by Western blotting as described previously [67]. Detection and
quantification of signals were performed using the infrared
imaging system Odyssey (LI-COR Biosciences) using fluoro-
phore-linked secondary antibodies (Molecular Probes and Rock-
land).
Quantitative RT-PCR (qRT-PCR)
Total RNA was isolated using Trizol LS reagent (Invitrogen).
Reverse transcription of total RNA was performed using oligo
(dT)18 as primer and Mu-MLV reverse transcriptase (Fermentas)
and the cDNA was subsequently used to amplify SOCS1 by qRT-
PCR. qRT-PCR was run on a Realplex Mastercycler (Eppendorf).
For SOCS1 and STING Quantitect Primer Assays (QIAGEN)
were used. For IFN-b, IFN-beta-fwd 59- TCAGAATGAGTGGT-
GGTTGC -39 and IFN-beta-rev 59 GACCTTTCAAATGCAG-
TAGATTCA 39 primers were used. For HPRT, the housekeeping
gene for normalization, the following primers were used: HPRT-
fwd 59-GGATTTGAATCACGTTTGTGTCAT-39, and HPRT-
rev 59-ACACCTGCTAATTTTACTGGCAA-39. Amplification
of DNA was monitored by SYBR Green (Molecular Probes) [68].
siRNA–mediated silencing
BMDMs were seeded on 6-cm dishes (2610
6 cells) in DMEM
containing 10% FCS and L-cell-derived CSF-1 without antibiot-
ics. Murine TBK1 and STING (ON-TARGETplus, Dharmacon)
siRNA (60 pmol), or a non-target control-siRNA were mixed with
1 ml Opti-MEM I reduced serum medium (GIBCO) and
transfected into BMDMs using 10 ml Lipofectamine RNAiMAX
(Invitrogen) according to the manufacturers instructions. 48 hrs
after transfection, medium was replaced by medium without
siRNA and antibiotics. After additional 24 hours cells were
infected with S. pyogenes (MOI=100).
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animal care (GZ 680 205/67-BrGt/2003). Animal experiments
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List of accession numbers in GenBank
IL6: NM_031168, MyD88: NM_010851, TLR2: NM_011905,
TLR4: NM_021297, TLR7: NM_133211, TBK1: NM_019786,
STING: NM_028261, MAVS: NM_144888, TRIF: NM_174989,
IRF1: NM_008390, IRF3: NM_016849, IRF5: NM_012057,
TLR3: NM_126166, TLR9: NM_031178, IFNAR1: NM_010508,
NOD1: NM_172729, NOD2: NM_145857, HPRT: NM_013556.
Supporting Information
Figure S1 cDCs produce higher amounts of IFN-b in response
to S. pyogenes than BMDMs. Both cell types respond in MOI-
dependent way. (A) BMDMs and cDCs were left untreated or
infected with S. pyogenes (MOI=100). At indicated time points
supernatants were collected and IFN-b release was measured.
Mean values 6 SD (n=3) are shown. (B) BMDMs and cDCs were
left untreated or infected with S. pyogenes at MOI=20, MOI=50
or MOI=100. Supernatants were collected after 6 h (cDCs) or
8 h (BMDMs) and IFN-b release was measured as in (A).
Found at: doi:10.1371/journal.ppat.1001345.s001 (0.17 MB TIF)
Figure S2 MyD88 deficiency results in stronger Stat1 activation
and reduced SOCS1 expression in response to S. pyogenes. Control
(WT) and MyD88
-/- BMDMs were infected with S. pyogenes (MOI
100) or left untreated. At indicated time points, either whole cell
extracts were prepared or total mRNA was extracted. (A) Stat1
activation was determined by Western blotting using antibody to
phosphorylated Stat1 (pY-S1). For loading control, the membrane
was reprobed using antibodies to total Stat1 (Stat1) and
p38MAPK (p38). Note the double band on the pY-S1 blot
represents the phosphorylated forms of both Stat1 splicing
isoforms Stat1-a and Stat1-b. Loading control (Stat1) was
performed with an antibody directed to the C-terminus of Stat1,
which is absent in the Stat1-b isoform. (B) total RNA was reverse-
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PLoS Pathogens | www.plospathogens.org 14 May 2011 | Volume 7 | Issue 5 | e1001345transcribed and analyzed by qPCR for SOCS1 expression after
normalization to HPRT. These data represent one of at least three
independent infection experiments with different mice from each
genotype.
Found at: doi:10.1371/journal.ppat.1001345.s002 (0.32 MB TIF)
Figure S3 TLR9 is not required for IFN-b induction by S.
pyogenes. Control (WT) and TLR9-/- BMDMs were infected with
S. pyogenes (MOI 100) and supernatants were collected at
indicated time points. IFN-b release was measured in three
independent infection experiments. Values represent mean 6 SD;
n=3.
Found at: doi:10.1371/journal.ppat.1001345.s003 (0.12 MB TIF)
Figure S4 Silencing efficiency of STING expression. BMDMs
were transfected with siRNA specific for STING or non-target
control siRNA. siRNA-treated cells were then infected with S.
pyogenes (MOI=100) or left uninfected (as described in Fig. 4F). At
indicated time-points, total RNA was extracted, reverse tran-
scribed and analyzed by qPCR for STING expression after
normalization to HPRT. These data represent one of at least three
independent infection experiments. Mean values 6 SD are shown
(n=3).
Found at: doi:10.1371/journal.ppat.1001345.s004 (0.17 MB TIF)
Figure S5 NOD1 and NOD2 are not required for IFN-b
induction by S. pyogenes. BMDMs from control (WT), NOD1
-/- or
NOD2
-/- mice were infected with S. pyogenes (MOI=100). Whole
cell extracts were prepared and supernatants were collected and at
indicated time points. (A) Stat1 activation was determined by
Western blotting using an antibody to phosphorylated Stat1 (pY-
S1). Antibody to total Stat1 was used for loading control. (B) IFN-b
release after 6 h of infection was measured in three independent
infection experiments. Values represent mean 6 SD; n=3.
Found at: doi:10.1371/journal.ppat.1001345.s005 (0.24 MB TIF)
Figure S6 Heat-killed S. pyogenes causes induction of IFN-b in
BMDMs and cDCs. BMDMs (A) and cDCs (B) were infected
with equal amounts of live and heat-killed S. pyogenes (MOI 100)
or left untreated. After the indicated time, supernatants were
collected and IFN-b release was measured using ELISA. Mean 6
SD; n=3.
Found at: doi:10.1371/journal.ppat.1001345.s006 (0.17 MB TIF)
Figure S7 The adaptor MAVS is not needed for IFN-b
induction by S. pyogenes in cDCs. cDCs from control (WT) and
MAVS
-/- mice were infected with S. pyogenes (MOI 100). After 4
and 6 h, supernatants were collected and IFN-b release was
measured using ELISA. Mean 6 SD; n=3.
Found at: doi:10.1371/journal.ppat.1001345.s007 (0.12 MB TIF)
Figure S8 Dynasore inhibits IFN-b production induced by
extracts derived from S. pyogenes. BMDMs were pretreated (for
45 min) with dynasore or left untreated. S. pyogenes cells were
sonicated and the extracts were treated with either DNase I,
RNase A, Proteinase K, or left untreated (control extract). These
extracts were delivered into BMDMs using DOTAP. After
stimulation for 8 h, supernatants were collected and IFN-b release
was measured using ELISA. Values represent mean 6 SD; n=3.
Found at: doi:10.1371/journal.ppat.1001345.s008 (0.11 MB TIF)
Figure S9 Plasmid DNA induces IFN-b production in BMDMs.
Plasmid pGEX was linearized by digestion with EcoRI, gel-
purified and eluted from DNA purification column. Five mg of the
linearized and purified pGEX DNA or S. pyogenes (SP)-derived
DNA were transfected into BMDMs using DOTAP. Supernatants
were collected 8 h later and IFN-b release was determined. Values
represent mean 6 SD; n=3.
Found at: doi:10.1371/journal.ppat.1001345.s009 (0.11 MB TIF)
Figure S10 DNA from Gram-positive bacteria does not induce
TNF after transfection into BMDMs. Purified DNA (5 mg/ml)
from S. pyogenes (SP), Group B streptococcus (GBS), Staphylococcus
aureus (SA), Listeria monocytogenes (LM), RAW 264.7 cells (RAW) and
poly(dA:dT) was delivered into BMDMs using DOTAP. After
stimulation for 8 h supernatants were collected and TNF release
was measured. Values represent mean 6 SD; n=3.
Found at: doi:10.1371/journal.ppat.1001345.s010 (0.12 MB TIF)
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